{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T19:37:28Z","timestamp":1769283448405,"version":"3.49.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.surg.2013.06.057","type":"journal-article","created":{"date-parts":[[2013,11,25]],"date-time":"2013-11-25T18:15:54Z","timestamp":1385403354000},"page":"217-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Ascidian (chordate-tunicate) and mammalian heparin enemas attenuate experimental diversion colitis"],"prefix":"10.1016","volume":"155","author":[{"suffix":"Jr.","given":"Valter","family":"Alvarenga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo Goulart","family":"Pacheco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiano Costa","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Buongusto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morgana Teixeira Lima","family":"Castelo-Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalil","family":"Madi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celso R.","family":"Belmiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro Sergio Gon\u00e7alves","family":"Pav\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heitor Siffert Pereira","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Schanaider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2013.06.057_bib1","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0016-5085(81)90003-2","article-title":"Proctitis and colitis following diversion of the fecal stream","volume":"80","author":"Glotzer","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2013.06.057_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0046-8177(90)90206-K","article-title":"Diversion colitis: a clinicopathologic study of 21 cases","volume":"21","author":"Ma","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1016\/j.surg.2013.06.057_bib3","first-page":"40","article-title":"Rectal bleeding due to diversion colitis","volume":"80","author":"Ona","year":"1985","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.surg.2013.06.057_bib4","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0016-5085(84)80081-5","article-title":"Aphthous ulceration in diversion colitis. Clinical implications","volume":"87","author":"Lusk","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2013.06.057_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02909487","article-title":"Diversion colitis. A prospective study","volume":"8","author":"Whelan","year":"1994","journal-title":"Surg Endosc"},{"key":"10.1016\/j.surg.2013.06.057_bib6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/gut.30.8.1094","article-title":"Impaired bacterial flora in human excluded colon","volume":"30","author":"Neut","year":"1989","journal-title":"Gut"},{"key":"10.1016\/j.surg.2013.06.057_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2559.1999.00624.x","article-title":"Diversion colitis: new light through old windows","volume":"34","author":"Edwards","year":"1999","journal-title":"Histopathology"},{"key":"10.1016\/j.surg.2013.06.057_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1590\/S0102-86502010000500002","article-title":"The importance of oxygen free radicals in the etiopathogenesis of diversion colitis in rats","volume":"25","author":"Martinez","year":"2010","journal-title":"Acta Cir Bras"},{"key":"10.1016\/j.surg.2013.06.057_bib9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/gut.40.3.400","article-title":"Oxidation of short and medium chain C2-C8 fatty acids in Sprague-Dawley rat colonocytes","volume":"40","author":"Jorgensen","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.surg.2013.06.057_bib10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clnu.2008.11.002","article-title":"Butyrate modulates oxidative stress in the colonic mucosa of healthy humans","volume":"28","author":"Hamer","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/j.surg.2013.06.057_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ibd.21108","article-title":"Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency","volume":"16","author":"Thibault","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.surg.2013.06.057_bib12","doi-asserted-by":"crossref","first-page":"e6759","DOI":"10.1371\/journal.pone.0006759","article-title":"Butyrate-induced transcriptional changes in human colonic mucosa","volume":"4","author":"Vanhoutvin","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.surg.2013.06.057_bib13","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.3748\/wjg.v18.i32.4278","article-title":"Use of butyrate or glutamine in enema solution reduces inflammation and fibrosis in experimental diversion colitis","volume":"18","author":"Pacheco","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2013.06.057_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","article-title":"Inflammatory bowel disease: etiology and pathogenesis","volume":"115","author":"Fiocchi","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2013.06.057_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.surg.2013.06.057_bib16","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1126\/science.1106442","article-title":"Immunity, inflammation, and allergy in the gut","volume":"307","author":"Macdonald","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.surg.2013.06.057_bib17","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1365-2796.2008.01953.x","article-title":"NF-kappaB in inflammatory bowel disease","volume":"263","author":"Atreya","year":"2008","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.surg.2013.06.057_bib18","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.20.100301.064816","article-title":"The immunology of mucosal models of inflammation","volume":"20","author":"Strober","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.surg.2013.06.057_bib19","first-page":"327","article-title":"The role of p38 mitogen-activated protein kinase in the pathogenesis of inflammatory bowel disease","volume":"12","author":"Feng","year":"2011","journal-title":"J\u00a0Dig Dis"},{"key":"10.1016\/j.surg.2013.06.057_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4899-2444-5_1","article-title":"Heparin - an introduction","volume":"313","author":"Rod\u00e9n","year":"1992","journal-title":"Adv Exp Med Biol"},{"issue":"1 Suppl","key":"10.1016\/j.surg.2013.06.057_bib21","doi-asserted-by":"crossref","first-page":"64S","DOI":"10.1378\/chest.119.1_suppl.64S","article-title":"Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety","volume":"119","author":"Hirsh","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.surg.2013.06.057_bib22","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1046\/j.1365-2036.2000.00860.x","article-title":"Review article: potential therapeutic applications and mechanisms of action of heparin in inflammatory bowel disease","volume":"14","author":"Papa","year":"2000","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.surg.2013.06.057_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1026184100030","article-title":"The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development","volume":"15","author":"Elsayed","year":"2003","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.surg.2013.06.057_bib24","doi-asserted-by":"crossref","first-page":"11267","DOI":"10.1074\/jbc.M807211200","article-title":"Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats","volume":"284","author":"Belmiro","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.surg.2013.06.057_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.thromres.2007.03.025","article-title":"Isolation and characterization of a heparin with low antithrombin activity from the body of Styela plicata (Chordata-Tunicata). Distinct effects on venous and arterial models of thrombosis","volume":"121","author":"Santos","year":"2007","journal-title":"Thromb Res"},{"key":"10.1016\/j.surg.2013.06.057_bib26","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1055\/s-0037-1616054","article-title":"Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding","volume":"86","author":"Vicente","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.surg.2013.06.057_bib27","doi-asserted-by":"crossref","first-page":"27848","DOI":"10.1074\/jbc.273.43.27848","article-title":"Highly sulfated dermatan sulfates from Ascidians. Structure versus anticoagulant activity of these glycosaminoglycans","volume":"273","author":"Pav\u00e3o","year":"1998","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.surg.2013.06.057_bib28","doi-asserted-by":"crossref","first-page":"31027","DOI":"10.1074\/jbc.270.52.31027","article-title":"A\u00a0unique dermatan sulfate-like glycosaminoglycan from ascidian. Its structure and the effect of its unusual sulfation pattern on anticoagulant activity","volume":"270","author":"Pav\u00e3o","year":"1995","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.surg.2013.06.057_bib29","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1590\/S0100-879X2006001100004","article-title":"In\u00a0vivo antithrombotic properties of a heparin from the oocyte test cells of the sea squirt Styela plicata (Chordata-Tunicata)","volume":"39","author":"Cardilo-Reis","year":"2006","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.surg.2013.06.057_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1590\/S0102-86502000000400002","article-title":"Colitis following fecal diversion: still a challenge","volume":"15","author":"Castro","year":"2000","journal-title":"Acta Cir Bras"},{"key":"10.1016\/j.surg.2013.06.057_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/BF02054992","article-title":"Diversion-related experimental colitis in rats","volume":"40","author":"Keli","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.surg.2013.06.057_bib32","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2036.2007.03418.x","article-title":"The utility and safety of heparin in the treatment of active ulcerative colitis","volume":"26","author":"Shen","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.surg.2013.06.057_bib33","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1002\/ibd.21776","article-title":"Unfractionated or low molecular weight heparin for induction of remission in ulcerative colitis: a Cochrane inflammatory bowel disease and functional bowel disorders systematic review of randomized trials","volume":"17","author":"Chande","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.surg.2013.06.057_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/DDDT.S11290","article-title":"Current and emerging drugs for the treatment of inflammatory bowel disease","volume":"5","author":"Triantafillidis","year":"2011","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.surg.2013.06.057_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2298\/ACI0803077S","article-title":"How to treat diversion colitis? Current state of medical knowledge, own research and experience","volume":"55","author":"Szczepkowski","year":"2008","journal-title":"Acta Chir Iugosl"},{"key":"10.1016\/j.surg.2013.06.057_bib36","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3748\/wjg.v19.i4.542","article-title":"Relationship between diversion colitis and quality of life in rectal cancer","volume":"19","author":"Son","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2013.06.057_bib37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.5482\/ha-1134","article-title":"Coagulation and inflammation. Molecular insights and diagnostic implications","volume":"31","author":"Lipinski","year":"2011","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.surg.2013.06.057_bib38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11239-006-9046-z","article-title":"Thrombin generation in mesalazine refractory ulcerative colitis and the influence of low molecular weight heparin","volume":"24","author":"Vrij","year":"2007","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.surg.2013.06.057_bib39","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ibd.20085","article-title":"Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis","volume":"13","author":"de Bi\u00e8vre","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.surg.2013.06.057_bib40","doi-asserted-by":"crossref","first-page":"690","DOI":"10.5414\/CPP42690","article-title":"A\u00a0comparison of observational studies and controlled trials of heparin in ulcerative colitis","volume":"42","author":"Malhotra","year":"2004","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.surg.2013.06.057_bib41","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2036.2008.03757.x","article-title":"Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis","volume":"28","author":"Pastorelli","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.surg.2013.06.057_bib42","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3748\/wjg.v5.i5.448","article-title":"Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin","volume":"5","author":"Cui","year":"1999","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.surg.2013.06.057_bib43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.biopha.2010.12.013","article-title":"Efficacy of oral colon-specific delivery capsule of low-molecular-weight heparin on ulcerative colitis","volume":"65","author":"Luo","year":"2011","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.surg.2013.06.057_bib44","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.biopha.2010.01.013","article-title":"Effect of low molecular weight heparin rectal suppository on experimental ulcerative colitis in mice","volume":"64","author":"Luo","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.surg.2013.06.057_bib45","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1007\/s10620-008-0299-6","article-title":"Efficacy of intracolonic administration of low-molecular-weight heparin CB-01-05, compared to other low-molecular-weight heparins and unfractionated heparin, in experimentally induced colitis in rat","volume":"53","author":"Celasco","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.surg.2013.06.057_bib46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1172\/JCI0214996","article-title":"Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins","volume":"110","author":"Wang","year":"2002","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.surg.2013.06.057_bib47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.maturitas.2008.11.008","article-title":"Crosstalk between inflammation and thrombosis","volume":"61","author":"Esmon","year":"2008","journal-title":"Maturitas"},{"key":"10.1016\/j.surg.2013.06.057_bib48","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","article-title":"Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation","volume":"81","author":"Kyriakis","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1016\/j.surg.2013.06.057_bib49","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.4049\/jimmunol.171.6.3194","article-title":"IL-6 induces Nfkappa B activation in the intestinal epithelia","volume":"171","author":"Wang","year":"2003","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.surg.2013.06.057_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0016-5085(95)90277-5","article-title":"Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)","volume":"109","author":"van Dullemen","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.surg.2013.06.057_bib51","doi-asserted-by":"crossref","first-page":"L77","DOI":"10.1152\/ajplung.00282.2006","article-title":"CD14 is an essential mediator of LPS-induced airway disease","volume":"293","author":"Brass","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.surg.2013.06.057_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.immunol.16.1.137","article-title":"Regulation of immune responses by TGF-beta","volume":"16","author":"Letterio","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.surg.2013.06.057_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4318\/tjg.2009.0002","article-title":"Plasma transforming growth factor-beta1 level in inflammatory bowel disease","volume":"20","author":"Kili\u00e7","year":"2009","journal-title":"Turk J Gastroenterol"},{"key":"10.1016\/j.surg.2013.06.057_bib54","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00054725-200102000-00003","article-title":"Inflammation location, but not type, determines the increase in TGF-beta1 and IGF-1 expression and collagen deposition in IBD intestine","volume":"7","author":"Lawrance","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.surg.2013.06.057_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00054725-200108000-00008","article-title":"Altered response of intestinal mucosal fibroblasts to profibrogenic cytokines in inflammatory bowel disease","volume":"7","author":"Lawrance","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.surg.2013.06.057_bib56","doi-asserted-by":"crossref","first-page":"36099","DOI":"10.1074\/jbc.M505291200","article-title":"Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2","volume":"280","author":"Theiss","year":"2005","journal-title":"J\u00a0Biol Chem"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606013003796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606013003796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:50:01Z","timestamp":1758538201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606013003796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0039606013003796"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2013.06.057","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ascidian (chordate-tunicate) and mammalian heparin enemas attenuate experimental diversion colitis","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2013.06.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}